Abstract
The tumor suppressor p16/CDKN2A/INK4a gene is frequently mutated, mostly by homozygous deletions in high-grade gliomas. Although the p16 protein suppresses cell proliferation primarily through inhibition of cell-cycle progression at the G1 phase, other phenotypic changes in glioma cells associated with p16INK4a alterations have not been fully described. To determine the roles of p16 alterations in glioma formation, we have established ecdysone-driven inducible p16 expression in the human glioblastoma cell line CL-4, which were derived from p16-null U87MG cells. Here we show that exogenous p16 expression in CL-4 cells results in morphological changes, with large and flattened cytoplasm, which are associated with increased formation of cytoplasmic actin-stress fibers and vinculin accumulation in the focal adhesion contacts. Adhesion of CL-4 cells to extracellular matrix proteins, such as laminin, fibronectin, and type IV collagen, significantly increased upon exogenous p16 expression, which correlated with increased expression of integrin alpha5 and alphav. Expression of a small GTP-binding protein, Rac, also decreased. Following epidermal growth factor stimulation, phosphorylation of MAP kinases ERK1 and 2 and induction of an ea...Continue Reading
References
Jan 1, 1992·Virchows Archiv. A, Pathological Anatomy and Histopathology·R M AgostiO D Wiestler
Nov 11, 1992·International Journal of Cancer. Journal International Du Cancer·R J WeinelS Santoso
Sep 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·C M Crews, R L Erikson
Oct 16, 1992·Science·C M CrewsR L Erikson
Aug 7, 1992·Cell·A J RidleyA Hall
May 17, 1991·Cell·T G BoultonG D Yancopoulos
Feb 1, 1989·Genomics·M FujimotoP J Sheridan
Jun 1, 1995·Molecular Biology of the Cell·J A VarnerR L Juliano
Apr 1, 1995·Molecular and Cellular Biology·R KozmaL Lim
Nov 1, 1994·Annals of Neurology·J W HensonD N Louis
Apr 21, 1994·Nature·T NoboriD A Carson
Apr 15, 1994·Science·A KambM H Skolnick
May 1, 1993·Journal of Neuro-oncology·W HamelH M Shepard
Dec 15, 1995·Cell·D E QuelleC J Sherr
Feb 1, 1996·Current Opinion in Cell Biology·S W Craig, R P Johnson
Feb 20, 1997·Oncogene·D LallemandC M Pfarr
Mar 1, 1997·Leukemia·B Martinez-DelgadoJ Benitez
Feb 24, 1997·Biochemical and Biophysical Research Communications·H HigashiM Kitagawa
Mar 28, 1997·Science·J LiR Parsons
Apr 1, 1997·Nature Genetics·P A SteckS V Tavtigian
Apr 22, 1997·International Journal of Cancer. Journal International Du Cancer·M FujitaY Murata
Jul 31, 1997·Oncogene·L UhrbomB Westermark
Nov 20, 1997·Oncogene·W ArapW K Cavenee
Nov 20, 1997·Oncogene·P B DirksJ T Rutka
Feb 7, 1998·Science·A Hall
Apr 7, 1998·Cell·Y ZhangW G Yarbrough
Jun 9, 1999·Journal of Neuro-oncology·H SawaI Saito
Nov 18, 2000·Experimental Cell Research·A A SchmitzL Van Aelst